Tag
The Federal Trade Commission and State of New York late last month filed a lawsuit against Martin Shkreli, charging that…
One question Julie Appleby posed to a panel she moderated on the high cost of prescription drugs was simple enough:…
•
David Abel had had enough. The Boston Globe’s environmental writer was used to being denied interviews with state scientists and…
Drawn by an influential lineup of speakers and panels – plus an intriguing offering of field trips – more than…
One of the best sessions at Health Journalism 2019 in Baltimore was the panel discussion about drug prices on May…
At some point almost all health care journalists will need to cover a medical study or two. When that happens,…
Researchers are looking to old drugs, plants and viruses in a race to find new ways to kill disease-causing microbes…
•
It’s an easy trap to fall into: call the hospital public relations department and ask to speak with an authority…
•
Are precision medicine and immunotherapy overhyped as cancer treatments, or do they hold such tremendous promise that we are only…
In just the past few years, telehealth has gained some momentum, in part spurred by the opioid epidemic and an…